MARIETTA, Ga., July 31, 2017 -- Optomap imaging technology identifies early signs of serious eye diseases and health conditions including diabetes and heart disease. These images are obtained instantly and it captures over 80 percent of the retina in one take. East Cobb Eye Center, located in Marietta Ga, offers this latest technology which provides more accurate eye disease diagnosis and management of eye conditions including cataracts, glaucoma, and macular degeneration.
The retina is a sensitive area in the back of the eye that exposes the state of blood vessels. With a traditional exam, an eye doctor can see only 15 percent of the retina. Unhealthy retinas can lead to impaired vision and blindness. Details from a traditional eye exam may be insufficient to identify the earliest signs of serious eye conditions, making it more challenging to monitor eye health. Optomap retinal imaging captures over three times of the retinal details available from a traditional eye exam, offering significantly more data to an eye doctor and their patient.
Optomap retinal exams use pioneering technology that offers enhanced accuracy during an eye exam. An optomap retinal image can be used to diagnose and monitor vision conditions including diabetic retinopathy, age-related macular degeneration, glaucoma, and hypertension. In addition to observing vision issues, eye doctors can recognize signs of heart disease, diabetes, and stroke. The exam with optomap retinal imaging is quick and painless and the images are available for review immediately.
“Optomap technology is a breakthrough advancing an eye doctor’s ability to evaluate eye health and improve eye condition diagnosis and treatment,” said Dr. Melissa Giannamore. “As an experienced optometrist, I see how optomap retinal imaging benefits our patients and allows our team to better serve their vision needs. Optomap is safe to use on children and adults and the technology has been used on millions of vision patients across the globe. Retinal digital imaging, as part of an eye exam, should be a must for those at risk of developing heart disease, diabetes, and glaucoma.”
About East Cobb Eye Center
Dr. Melissa Giannamore, Board Certified Optometric Physician at East Cobb Eye Center, serves residents of Marietta and surrounding areas. Patients can expect high-quality eye care services in a comfortable environment. Services at East Cobb Eye Center include comprehensive medical eye exams as well as treatment and management of ocular disease, and optomap retinal imaging.
Call (770) 642-4001 to learn about optomap eye exams for retinal imaging, schedule an eye exam, or visit http://www.eastcobbeyecenter.com/ for details.
East Cobb Eye Center 3960 Shallowford Road Suite A Marietta, GA, 30062 (770) 642-4001


Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



